APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hospital and Nursing Home Probiotics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Hospital and Nursing Home Probiotics Market Analysis and Forecast 2026-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchHospital and Nursing Home Probiotics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Hospital and Nursing Home Probiotics Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Hospital and Nursing Home Probiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hospital and Nursing Home Probiotics Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Hospital and Nursing Home Probiotics Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Hospital and Nursing Home Probiotics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hospital and Nursing Home Probiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Hospital and Nursing Home Probiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Hospital and Nursing Home Probiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Hospital and Nursing Home Probiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Hospital and Nursing Home Probiotics include American Lifeline, Becton Dickinson and Company, Bio - K Plus International, Eva Nutra, Mercola, Nebraska Cultures, Nutraceutix, NutraScience Labs and Probium, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hospital and Nursing Home Probiotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hospital and Nursing Home Probiotics, also provides the sales of main regions and countries. Of the upcoming market potential for Hospital and Nursing Home Probiotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hospital and Nursing Home Probiotics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hospital and Nursing Home Probiotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hospital and Nursing Home Probiotics sales, projected growth trends, production technology, application and end-user industry.

Hospital and Nursing Home Probiotics Segment by Company

American Lifeline

Becton Dickinson and Company

Bio - K Plus International

Eva Nutra

Mercola

Nebraska Cultures

Nutraceutix

NutraScience Labs

Probium

Protexin

Rising Pharmaceuticals

UP4 Probiotics

Vitakem Nutraceuticals

Hospital and Nursing Home Probiotics Segment by Type

Gram-positive Cocci

Lactobacillus

Bifidobacterium

Others

Hospital and Nursing Home Probiotics Segment by Application

Immunity

Wellness

Gut Health

Others

Hospital and Nursing Home Probiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital and Nursing Home Probiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hospital and Nursing Home Probiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital and Nursing Home Probiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hospital and Nursing Home Probiotics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hospital and Nursing Home Probiotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hospital and Nursing Home Probiotics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hospital and Nursing Home Probiotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Gram-positive Cocci Major Manufacturers Table 3. Lactobacillus Major Manufacturers Table 4. Bifidobacterium Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Hospital and Nursing Home Probiotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Immunity Major Manufacturers Table 8. Wellness Major Manufacturers Table 9. Gut Health Major Manufacturers Table 10. Others Major Manufacturers Table 11. Hospital and Nursing Home Probiotics Industry Trends Table 12. Hospital and Nursing Home Probiotics Industry Drivers Table 13. Hospital and Nursing Home Probiotics Industry Opportunities and Challenges Table 14. Hospital and Nursing Home Probiotics Industry Restraints Table 15. Global Hospital and Nursing Home Probiotics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Hospital and Nursing Home Probiotics Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Hospital and Nursing Home Probiotics Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Hospital and Nursing Home Probiotics Revenue Market Share by Region (2021-2026) Table 19. Global Hospital and Nursing Home Probiotics Revenue Market Share by Region (2027-2032) Table 20. Global Hospital and Nursing Home Probiotics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Hospital and Nursing Home Probiotics Sales by Region (2021-2026) & (k units) Table 22. Global Hospital and Nursing Home Probiotics Sales by Region (2027-2032) & (k units) Table 23. Global Hospital and Nursing Home Probiotics Sales Market Share by Region (2021-2026) Table 24. Global Hospital and Nursing Home Probiotics Sales Market Share by Region (2027-2032) Table 25. Global Hospital and Nursing Home Probiotics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Hospital and Nursing Home Probiotics Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Hospital and Nursing Home Probiotics Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Hospital and Nursing Home Probiotics Sales Market Share by Manufacturers (2021-2026) Table 29. Global Hospital and Nursing Home Probiotics Sales Price (US$/unit) of Manufacturers (2021-2026) Table 30. Global Hospital and Nursing Home Probiotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Hospital and Nursing Home Probiotics Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Hospital and Nursing Home Probiotics Manufacturers, Product Type & Application Table 33. Global Hospital and Nursing Home Probiotics Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Hospital and Nursing Home Probiotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Hospital and Nursing Home Probiotics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Hospital and Nursing Home Probiotics Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Hospital and Nursing Home Probiotics Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Hospital and Nursing Home Probiotics Revenue Market Share by Type (2021-2026) Table 40. Global Hospital and Nursing Home Probiotics Revenue Market Share by Type (2027-2032) Table 41. Global Hospital and Nursing Home Probiotics Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Hospital and Nursing Home Probiotics Sales by Type (2021-2026) & (k units) Table 43. Global Hospital and Nursing Home Probiotics Sales by Type (2027-2032) & (k units) Table 44. Global Hospital and Nursing Home Probiotics Sales Market Share by Type (2021-2026) Table 45. Global Hospital and Nursing Home Probiotics Sales Market Share by Type (2027-2032) Table 46. Global Hospital and Nursing Home Probiotics Price by Type (2021-2026) & (US$/unit) Table 47. Global Hospital and Nursing Home Probiotics Price by Type (2027-2032) & (US$/unit) Table 48. Global Hospital and Nursing Home Probiotics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Hospital and Nursing Home Probiotics Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Hospital and Nursing Home Probiotics Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Hospital and Nursing Home Probiotics Revenue Market Share by Application (2021-2026) Table 52. Global Hospital and Nursing Home Probiotics Revenue Market Share by Application (2027-2032) Table 53. Global Hospital and Nursing Home Probiotics Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Hospital and Nursing Home Probiotics Sales by Application (2021-2026) & (k units) Table 55. Global Hospital and Nursing Home Probiotics Sales by Application (2027-2032) & (k units) Table 56. Global Hospital and Nursing Home Probiotics Sales Market Share by Application (2021-2026) Table 57. Global Hospital and Nursing Home Probiotics Sales Market Share by Application (2027-2032) Table 58. Global Hospital and Nursing Home Probiotics Price by Application (2021-2026) & (US$/unit) Table 59. Global Hospital and Nursing Home Probiotics Price by Application (2027-2032) & (US$/unit) Table 60. American Lifeline Company Information Table 61. American Lifeline Business Overview Table 62. American Lifeline Hospital and Nursing Home Probiotics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 63. American Lifeline Hospital and Nursing Home Probiotics Product Portfolio Table 64. American Lifeline Recent Development Table 65. Becton Dickinson and Company Company Information Table 66. Becton Dickinson and Company Business Overview Table 67. Becton Dickinson and Company Hospital and Nursing Home Probiotics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Becton Dickinson and Company Hospital and Nursing Home Probiotics Product Portfolio Table 69. Becton Dickinson and Company Recent Development Table 70. Bio - K Plus International Company Information Table 71. Bio - K Plus International Business Overview Table 72. Bio - K Plus International Hospital and Nursing Home Probiotics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Bio - K Plus International Hospital and Nursing Home Probiotics Product Portfolio Table 74. Bio - K Plus International Recent Development Table 75. Eva Nutra Company Information Table 76. Eva Nutra Business Overview Table 77. Eva Nutra Hospital and Nursing Home Probiotics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Eva Nutra Hospital and Nursing Home Probiotics Product Portfolio Table 79. Eva Nutra Recent Development Table 80. Mercola Company Information Table 81. Mercola Business Overview Table 82. Mercola Hospital and Nursing Home Probiotics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Mercola Hospital and Nursing Home Probiotics Product Portfolio Table 84. Mercola Recent Development Table 85. Nebraska Cultures Company Information Table 86. Nebraska Cultures Business Overview Table 87. Nebraska Cultures Hospital and Nursing Home Probiotics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Nebraska Cultures Hospital and Nursing Home Probiotics Product Portfolio Table 89. Nebraska Cultures Recent Development Table 90. Nutraceutix Company Information Table 91. Nutraceutix Business Overview Table 92. Nutraceutix Hospital and Nursing Home Probiotics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Nutraceutix Hospital and Nursing Home Probiotics Product Portfolio Table 94. Nutraceutix Recent Development Table 95. NutraScience Labs Company Information Table 96. NutraScience Labs Business Overview Table 97. NutraScience Labs Hospital and Nursing Home Probiotics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. NutraScience Labs Hospital and Nursing Home Probiotics Product Portfolio Table 99. NutraScience Labs Recent Development Table 100. Probium Company Information Table 101. Probium Business Overview Table 102. Probium Hospital and Nursing Home Probiotics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Probium Hospital and Nursing Home Probiotics Product Portfolio Table 104. Probium Recent Development Table 105. Protexin Company Information Table 106. Protexin Business Overview Table 107. Protexin Hospital and Nursing Home Probiotics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Protexin Hospital and Nursing Home Probiotics Product Portfolio Table 109. Protexin Recent Development Table 110. Rising Pharmaceuticals Company Information Table 111. Rising Pharmaceuticals Business Overview Table 112. Rising Pharmaceuticals Hospital and Nursing Home Probiotics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Rising Pharmaceuticals Hospital and Nursing Home Probiotics Product Portfolio Table 114. Rising Pharmaceuticals Recent Development Table 115. UP4 Probiotics Company Information Table 116. UP4 Probiotics Business Overview Table 117. UP4 Probiotics Hospital and Nursing Home Probiotics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. UP4 Probiotics Hospital and Nursing Home Probiotics Product Portfolio Table 119. UP4 Probiotics Recent Development Table 120. Vitakem Nutraceuticals Company Information Table 121. Vitakem Nutraceuticals Business Overview Table 122. Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Product Portfolio Table 124. Vitakem Nutraceuticals Recent Development Table 125. North America Hospital and Nursing Home Probiotics Revenue by Type (2021-2026) & (US$ Million) Table 126. North America Hospital and Nursing Home Probiotics Revenue by Type (2027-2032) & (US$ Million) Table 127. North America Hospital and Nursing Home Probiotics Sales by Type (2021-2026) & (k units) Table 128. North America Hospital and Nursing Home Probiotics Sales by Type (2027-2032) & (k units) Table 129. North America Hospital and Nursing Home Probiotics Sales Price by Type (2021-2026) & (US$/unit) Table 130. North America Hospital and Nursing Home Probiotics Sales Price by Type (2027-2032) & (US$/unit) Table 131. North America Hospital and Nursing Home Probiotics Revenue by Application (2021-2026) & (US$ Million) Table 132. North America Hospital and Nursing Home Probiotics Revenue by Application (2027-2032) & (US$ Million) Table 133. North America Hospital and Nursing Home Probiotics Sales by Application (2021-2026) & (k units) Table 134. North America Hospital and Nursing Home Probiotics Sales by Application (2027-2032) & (k units) Table 135. North America Hospital and Nursing Home Probiotics Sales Price by Application (2021-2026) & (US$/unit) Table 136. North America Hospital and Nursing Home Probiotics Sales Price by Application (2027-2032) & (US$/unit) Table 137. North America Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. North America Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. North America Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. North America Hospital and Nursing Home Probiotics Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 141. North America Hospital and Nursing Home Probiotics Sales by Country (2021-2026) & (k units) Table 142. North America Hospital and Nursing Home Probiotics Sales by Country (2027-2032) & (k units) Table 143. North America Hospital and Nursing Home Probiotics Sales Price by Country (2021-2026) & (US$/unit) Table 144. North America Hospital and Nursing Home Probiotics Sales Price by Country (2027-2032) & (US$/unit) Table 145. United States Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 146. Canada Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 147. Mexico Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 148. Europe Hospital and Nursing Home Probiotics Revenue by Type (2021-2026) & (US$ Million) Table 149. Europe Hospital and Nursing Home Probiotics Revenue by Type (2027-2032) & (US$ Million) Table 150. Europe Hospital and Nursing Home Probiotics Sales by Type (2021-2026) & (k units) Table 151. Europe Hospital and Nursing Home Probiotics Sales by Type (2027-2032) & (k units) Table 152. Europe Hospital and Nursing Home Probiotics Sales Price by Type (2021-2026) & (US$/unit) Table 153. Europe Hospital and Nursing Home Probiotics Sales Price by Type (2027-2032) & (US$/unit) Table 154. Europe Hospital and Nursing Home Probiotics Revenue by Application (2021-2026) & (US$ Million) Table 155. Europe Hospital and Nursing Home Probiotics Revenue by Application (2027-2032) & (US$ Million) Table 156. Europe Hospital and Nursing Home Probiotics Sales by Application (2021-2026) & (k units) Table 157. Europe Hospital and Nursing Home Probiotics Sales by Application (2027-2032) & (k units) Table 158. Europe Hospital and Nursing Home Probiotics Sales Price by Application (2021-2026) & (US$/unit) Table 159. Europe Hospital and Nursing Home Probiotics Sales Price by Application (2027-2032) & (US$/unit) Table 160. Europe Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Europe Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. Europe Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. Europe Hospital and Nursing Home Probiotics Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 164. Europe Hospital and Nursing Home Probiotics Sales by Country (2021-2026) & (k units) Table 165. Europe Hospital and Nursing Home Probiotics Sales by Country (2027-2032) & (k units) Table 166. Europe Hospital and Nursing Home Probiotics Sales Price by Country (2021-2026) & (US$/unit) Table 167. Europe Hospital and Nursing Home Probiotics Sales Price by Country (2027-2032) & (US$/unit) Table 168. Germany Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 169. France Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 170. U.K. Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 171. Italy Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 172. Russia Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 173. Spain Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 174. Netherlands Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 175. Switzerland Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 176. Sweden Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 177. Poland Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 178. China Hospital and Nursing Home Probiotics Revenue by Type (2021-2026) & (US$ Million) Table 179. China Hospital and Nursing Home Probiotics Revenue by Type (2027-2032) & (US$ Million) Table 180. China Hospital and Nursing Home Probiotics Sales by Type (2021-2026) & (k units) Table 181. China Hospital and Nursing Home Probiotics Sales by Type (2027-2032) & (k units) Table 182. China Hospital and Nursing Home Probiotics Sales Price by Type (2021-2026) & (US$/unit) Table 183. China Hospital and Nursing Home Probiotics Sales Price by Type (2027-2032) & (US$/unit) Table 184. China Hospital and Nursing Home Probiotics Revenue by Application (2021-2026) & (US$ Million) Table 185. China Hospital and Nursing Home Probiotics Revenue by Application (2027-2032) & (US$ Million) Table 186. China Hospital and Nursing Home Probiotics Sales by Application (2021-2026) & (k units) Table 187. China Hospital and Nursing Home Probiotics Sales by Application (2027-2032) & (k units) Table 188. China Hospital and Nursing Home Probiotics Sales Price by Application (2021-2026) & (US$/unit) Table 189. China Hospital and Nursing Home Probiotics Sales Price by Application (2027-2032) & (US$/unit) Table 190. Asia Hospital and Nursing Home Probiotics Revenue by Type (2021-2026) & (US$ Million) Table 191. Asia Hospital and Nursing Home Probiotics Revenue by Type (2027-2032) & (US$ Million) Table 192. Asia Hospital and Nursing Home Probiotics Sales by Type (2021-2026) & (k units) Table 193. Asia Hospital and Nursing Home Probiotics Sales by Type (2027-2032) & (k units) Table 194. Asia Hospital and Nursing Home Probiotics Sales Price by Type (2021-2026) & (US$/unit) Table 195. Asia Hospital and Nursing Home Probiotics Sales Price by Type (2027-2032) & (US$/unit) Table 196. Asia Hospital and Nursing Home Probiotics Revenue by Application (2021-2026) & (US$ Million) Table 197. Asia Hospital and Nursing Home Probiotics Revenue by Application (2027-2032) & (US$ Million) Table 198. Asia Hospital and Nursing Home Probiotics Sales by Application (2021-2026) & (k units) Table 199. Asia Hospital and Nursing Home Probiotics Sales by Application (2027-2032) & (k units) Table 200. Asia Hospital and Nursing Home Probiotics Sales Price by Application (2021-2026) & (US$/unit) Table 201. Asia Hospital and Nursing Home Probiotics Sales Price by Application (2027-2032) & (US$/unit) Table 202. Asia Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. Asia Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. Asia Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. Asia Hospital and Nursing Home Probiotics Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 206. Asia Hospital and Nursing Home Probiotics Sales by Country (2021-2026) & (k units) Table 207. Asia Hospital and Nursing Home Probiotics Sales by Country (2027-2032) & (k units) Table 208. Asia Hospital and Nursing Home Probiotics Sales Price by Country (2021-2026) & (US$/unit) Table 209. Asia Hospital and Nursing Home Probiotics Sales Price by Country (2027-2032) & (US$/unit) Table 210. Japan Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 211. South Korea Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 212. India Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 213. Australia Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 214. Taiwan Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 215. Southeast Asia Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 216. SAMEA Hospital and Nursing Home Probiotics Revenue by Type (2021-2026) & (US$ Million) Table 217. SAMEA Hospital and Nursing Home Probiotics Revenue by Type (2027-2032) & (US$ Million) Table 218. SAMEA Hospital and Nursing Home Probiotics Sales by Type (2021-2026) & (k units) Table 219. SAMEA Hospital and Nursing Home Probiotics Sales by Type (2027-2032) & (k units) Table 220. SAMEA Hospital and Nursing Home Probiotics Sales Price by Type (2021-2026) & (US$/unit) Table 221. SAMEA Hospital and Nursing Home Probiotics Sales Price by Type (2027-2032) & (US$/unit) Table 222. SAMEA Hospital and Nursing Home Probiotics Revenue by Application (2021-2026) & (US$ Million) Table 223. SAMEA Hospital and Nursing Home Probiotics Revenue by Application (2027-2032) & (US$ Million) Table 224. SAMEA Hospital and Nursing Home Probiotics Sales by Application (2021-2026) & (k units) Table 225. SAMEA Hospital and Nursing Home Probiotics Sales by Application (2027-2032) & (k units) Table 226. SAMEA Hospital and Nursing Home Probiotics Sales Price by Application (2021-2026) & (US$/unit) Table 227. SAMEA Hospital and Nursing Home Probiotics Sales Price by Application (2027-2032) & (US$/unit) Table 228. SAMEA Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. SAMEA Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. SAMEA Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. SAMEA Hospital and Nursing Home Probiotics Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 232. SAMEA Hospital and Nursing Home Probiotics Sales by Country (2021-2026) & (k units) Table 233. SAMEA Hospital and Nursing Home Probiotics Sales by Country (2027-2032) & (k units) Table 234. SAMEA Hospital and Nursing Home Probiotics Sales Price by Country (2021-2026) & (US$/unit) Table 235. SAMEA Hospital and Nursing Home Probiotics Sales Price by Country (2027-2032) & (US$/unit) Table 236. Brazil Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 237. Argentina Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 238. Chile Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 239. Colombia Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 240. Peru Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 241. Saudi Arabia Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 242. Israel Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 243. UAE Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 244. Turkey Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 245. Iran Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 246. Egypt Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Table 247. Key Raw Materials Table 248. Raw Materials Key Suppliers Table 249. Hospital and Nursing Home Probiotics Distributors List Table 250. Hospital and Nursing Home Probiotics Customers List Table 251. Research Programs/Design for This Report Table 252. Authors List of This Report Table 253. Secondary Sources Table 254. Primary Sources List of Figures Figure 1. Hospital and Nursing Home Probiotics Image Figure 2. Global Hospital and Nursing Home Probiotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hospital and Nursing Home Probiotics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Gram-positive Cocci Image Figure 5. Lactobacillus Image Figure 6. Bifidobacterium Image Figure 7. Others Image Figure 8. Global Hospital and Nursing Home Probiotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Hospital and Nursing Home Probiotics Market Size Share 2021 VS 2025 VS 2032 Figure 10. Immunity Image Figure 11. Wellness Image Figure 12. Gut Health Image Figure 13. Others Image Figure 14. Global Hospital and Nursing Home Probiotics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Hospital and Nursing Home Probiotics Revenue (2021-2032) & (US$ Million) Figure 16. Global Hospital and Nursing Home Probiotics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Hospital and Nursing Home Probiotics Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Hospital and Nursing Home Probiotics Revenue Market Share by Region (2021-2032) Figure 19. Global Hospital and Nursing Home Probiotics Sales (2021-2032) & (k units) Figure 20. Global Hospital and Nursing Home Probiotics Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Hospital and Nursing Home Probiotics Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Hospital and Nursing Home Probiotics Sales YoY (2021-2032) & (k units) Figure 23. Europe Hospital and Nursing Home Probiotics Sales YoY (2021-2032) & (k units) Figure 24. China Hospital and Nursing Home Probiotics Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Hospital and Nursing Home Probiotics Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Hospital and Nursing Home Probiotics Sales YoY (2021-2032) & (k units) Figure 27. Global Hospital and Nursing Home Probiotics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Hospital and Nursing Home Probiotics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Hospital and Nursing Home Probiotics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Hospital and Nursing Home Probiotics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Hospital and Nursing Home Probiotics Revenue Market Share by Type (2021-2032) Figure 33. Global Hospital and Nursing Home Probiotics Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Hospital and Nursing Home Probiotics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Hospital and Nursing Home Probiotics Sales Market Share by Type (2021-2032) Figure 36. Global Hospital and Nursing Home Probiotics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Hospital and Nursing Home Probiotics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Hospital and Nursing Home Probiotics Revenue Market Share by Application (2021-2032) Figure 39. Global Hospital and Nursing Home Probiotics Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Hospital and Nursing Home Probiotics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Hospital and Nursing Home Probiotics Sales Market Share by Application (2021-2032) Figure 42. North America Hospital and Nursing Home Probiotics Revenue Share by Type (2021-2032) Figure 43. North America Hospital and Nursing Home Probiotics Sales Share by Type (2021-2032) Figure 44. North America Hospital and Nursing Home Probiotics Revenue Share by Application (2021-2032) Figure 45. North America Hospital and Nursing Home Probiotics Sales Share by Application (2021-2032) Figure 46. North America Hospital and Nursing Home Probiotics Revenue Share by Country (2021-2032) Figure 47. North America Hospital and Nursing Home Probiotics Sales Share by Country (2021-2032) Figure 48. Europe Hospital and Nursing Home Probiotics Revenue Share by Type (2021-2032) Figure 49. Europe Hospital and Nursing Home Probiotics Sales Share by Type (2021-2032) Figure 50. Europe Hospital and Nursing Home Probiotics Revenue Share by Application (2021-2032) Figure 51. Europe Hospital and Nursing Home Probiotics Sales Share by Application (2021-2032) Figure 52. Europe Hospital and Nursing Home Probiotics Revenue Share by Country (2021-2032) Figure 53. Europe Hospital and Nursing Home Probiotics Sales Share by Country (2021-2032) Figure 54. China Hospital and Nursing Home Probiotics Revenue Share by Type (2021-2032) Figure 55. China Hospital and Nursing Home Probiotics Sales Share by Type (2021-2032) Figure 56. China Hospital and Nursing Home Probiotics Revenue Share by Application (2021-2032) Figure 57. China Hospital and Nursing Home Probiotics Sales Share by Application (2021-2032) Figure 58. Asia Hospital and Nursing Home Probiotics Revenue Share by Type (2021-2032) Figure 59. Asia Hospital and Nursing Home Probiotics Sales Share by Type (2021-2032) Figure 60. Asia Hospital and Nursing Home Probiotics Revenue Share by Application (2021-2032) Figure 61. Asia Hospital and Nursing Home Probiotics Sales Share by Application (2021-2032) Figure 62. Asia Hospital and Nursing Home Probiotics Revenue Share by Country (2021-2032) Figure 63. Asia Hospital and Nursing Home Probiotics Sales Share by Country (2021-2032) Figure 64. SAMEA Hospital and Nursing Home Probiotics Revenue Share by Type (2021-2032) Figure 65. SAMEA Hospital and Nursing Home Probiotics Sales Share by Type (2021-2032) Figure 66. SAMEA Hospital and Nursing Home Probiotics Revenue Share by Application (2021-2032) Figure 67. SAMEA Hospital and Nursing Home Probiotics Sales Share by Application (2021-2032) Figure 68. SAMEA Hospital and Nursing Home Probiotics Revenue Share by Country (2021-2032) Figure 69. SAMEA Hospital and Nursing Home Probiotics Sales Share by Country (2021-2032) Figure 70. Hospital and Nursing Home Probiotics Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Hospital and Nursing Home Probiotics Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Gram-positive Cocci
  • Lactobacillus
  • Bifidobacterium
  • Others
Applications
  • Immunity
  • Wellness
  • Gut Health
  • Others
Companies covered
  • American Lifeline
  • Becton Dickinson and Company
  • Bio - K Plus International
  • Eva Nutra
  • Mercola
  • Nebraska Cultures
  • Nutraceutix
  • NutraScience Labs
  • Probium
  • Protexin
  • Rising Pharmaceuticals
  • UP4 Probiotics
  • Vitakem Nutraceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hospital and Nursing Home Probiotics Market by Type
  3. 1.2.1 Global Hospital and Nursing Home Probiotics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Gram-positive Cocci
  5. 1.2.3 Lactobacillus
  6. 1.2.4 Bifidobacterium
  7. 1.2.5 Others
  8. 1.3 Hospital and Nursing Home Probiotics Market by Application
  9. 1.3.1 Global Hospital and Nursing Home Probiotics Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Immunity
  11. 1.3.3 Wellness
  12. 1.3.4 Gut Health
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Hospital and Nursing Home Probiotics Market Dynamics
  1. 2.1 Hospital and Nursing Home Probiotics Industry Trends
  2. 2.2 Hospital and Nursing Home Probiotics Industry Drivers
  3. 2.3 Hospital and Nursing Home Probiotics Industry Opportunities and Challenges
  4. 2.4 Hospital and Nursing Home Probiotics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hospital and Nursing Home Probiotics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hospital and Nursing Home Probiotics Revenue by Region
  3. 3.2.1 Global Hospital and Nursing Home Probiotics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hospital and Nursing Home Probiotics Revenue by Region (2021-2026)
  5. 3.2.3 Global Hospital and Nursing Home Probiotics Revenue by Region (2027-2032)
  6. 3.2.4 Global Hospital and Nursing Home Probiotics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hospital and Nursing Home Probiotics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hospital and Nursing Home Probiotics Sales by Region
  9. 3.4.1 Global Hospital and Nursing Home Probiotics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hospital and Nursing Home Probiotics Sales by Region (2021-2026)
  11. 3.4.3 Global Hospital and Nursing Home Probiotics Sales by Region (2027-2032)
  12. 3.4.4 Global Hospital and Nursing Home Probiotics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hospital and Nursing Home Probiotics Revenue by Manufacturers
  2. 4.1.1 Global Hospital and Nursing Home Probiotics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hospital and Nursing Home Probiotics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hospital and Nursing Home Probiotics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hospital and Nursing Home Probiotics Sales by Manufacturers
  6. 4.2.1 Global Hospital and Nursing Home Probiotics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hospital and Nursing Home Probiotics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hospital and Nursing Home Probiotics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hospital and Nursing Home Probiotics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hospital and Nursing Home Probiotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hospital and Nursing Home Probiotics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hospital and Nursing Home Probiotics Manufacturers, Product Type & Application
  13. 4.7 Global Hospital and Nursing Home Probiotics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hospital and Nursing Home Probiotics Market CR5 and HHI
  16. 4.8.2 2025 Hospital and Nursing Home Probiotics Tier 1, Tier 2, and Tier 3
5 Hospital and Nursing Home Probiotics Market by Type
  1. 5.1 Global Hospital and Nursing Home Probiotics Revenue by Type
  2. 5.1.1 Global Hospital and Nursing Home Probiotics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hospital and Nursing Home Probiotics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hospital and Nursing Home Probiotics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hospital and Nursing Home Probiotics Sales by Type
  6. 5.2.1 Global Hospital and Nursing Home Probiotics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hospital and Nursing Home Probiotics Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Hospital and Nursing Home Probiotics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hospital and Nursing Home Probiotics Price by Type
6 Hospital and Nursing Home Probiotics Market by Application
  1. 6.1 Global Hospital and Nursing Home Probiotics Revenue by Application
  2. 6.1.1 Global Hospital and Nursing Home Probiotics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hospital and Nursing Home Probiotics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hospital and Nursing Home Probiotics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hospital and Nursing Home Probiotics Sales by Application
  6. 6.2.1 Global Hospital and Nursing Home Probiotics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hospital and Nursing Home Probiotics Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Hospital and Nursing Home Probiotics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hospital and Nursing Home Probiotics Price by Application
7 Company Profiles
  1. 7.1 American Lifeline
  2. 7.1.1 American Lifeline Company Information
  3. 7.1.2 American Lifeline Business Overview
  4. 7.1.3 American Lifeline Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 American Lifeline Hospital and Nursing Home Probiotics Product Portfolio
  6. 7.1.5 American Lifeline Recent Developments
  7. 7.2 Becton Dickinson and Company
  8. 7.2.1 Becton Dickinson and Company Company Information
  9. 7.2.2 Becton Dickinson and Company Business Overview
  10. 7.2.3 Becton Dickinson and Company Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Becton Dickinson and Company Hospital and Nursing Home Probiotics Product Portfolio
  12. 7.2.5 Becton Dickinson and Company Recent Developments
  13. 7.3 Bio - K Plus International
  14. 7.3.1 Bio - K Plus International Company Information
  15. 7.3.2 Bio - K Plus International Business Overview
  16. 7.3.3 Bio - K Plus International Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bio - K Plus International Hospital and Nursing Home Probiotics Product Portfolio
  18. 7.3.5 Bio - K Plus International Recent Developments
  19. 7.4 Eva Nutra
  20. 7.4.1 Eva Nutra Company Information
  21. 7.4.2 Eva Nutra Business Overview
  22. 7.4.3 Eva Nutra Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Eva Nutra Hospital and Nursing Home Probiotics Product Portfolio
  24. 7.4.5 Eva Nutra Recent Developments
  25. 7.5 Mercola
  26. 7.5.1 Mercola Company Information
  27. 7.5.2 Mercola Business Overview
  28. 7.5.3 Mercola Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mercola Hospital and Nursing Home Probiotics Product Portfolio
  30. 7.5.5 Mercola Recent Developments
  31. 7.6 Nebraska Cultures
  32. 7.6.1 Nebraska Cultures Company Information
  33. 7.6.2 Nebraska Cultures Business Overview
  34. 7.6.3 Nebraska Cultures Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Nebraska Cultures Hospital and Nursing Home Probiotics Product Portfolio
  36. 7.6.5 Nebraska Cultures Recent Developments
  37. 7.7 Nutraceutix
  38. 7.7.1 Nutraceutix Company Information
  39. 7.7.2 Nutraceutix Business Overview
  40. 7.7.3 Nutraceutix Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Nutraceutix Hospital and Nursing Home Probiotics Product Portfolio
  42. 7.7.5 Nutraceutix Recent Developments
  43. 7.8 NutraScience Labs
  44. 7.8.1 NutraScience Labs Company Information
  45. 7.8.2 NutraScience Labs Business Overview
  46. 7.8.3 NutraScience Labs Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 NutraScience Labs Hospital and Nursing Home Probiotics Product Portfolio
  48. 7.8.5 NutraScience Labs Recent Developments
  49. 7.9 Probium
  50. 7.9.1 Probium Company Information
  51. 7.9.2 Probium Business Overview
  52. 7.9.3 Probium Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Probium Hospital and Nursing Home Probiotics Product Portfolio
  54. 7.9.5 Probium Recent Developments
  55. 7.10 Protexin
  56. 7.10.1 Protexin Company Information
  57. 7.10.2 Protexin Business Overview
  58. 7.10.3 Protexin Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Protexin Hospital and Nursing Home Probiotics Product Portfolio
  60. 7.10.5 Protexin Recent Developments
  61. 7.11 Rising Pharmaceuticals
  62. 7.11.1 Rising Pharmaceuticals Company Information
  63. 7.11.2 Rising Pharmaceuticals Business Overview
  64. 7.11.3 Rising Pharmaceuticals Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Rising Pharmaceuticals Hospital and Nursing Home Probiotics Product Portfolio
  66. 7.11.5 Rising Pharmaceuticals Recent Developments
  67. 7.12 UP4 Probiotics
  68. 7.12.1 UP4 Probiotics Company Information
  69. 7.12.2 UP4 Probiotics Business Overview
  70. 7.12.3 UP4 Probiotics Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 UP4 Probiotics Hospital and Nursing Home Probiotics Product Portfolio
  72. 7.12.5 UP4 Probiotics Recent Developments
  73. 7.13 Vitakem Nutraceuticals
  74. 7.13.1 Vitakem Nutraceuticals Company Information
  75. 7.13.2 Vitakem Nutraceuticals Business Overview
  76. 7.13.3 Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Product Portfolio
  78. 7.13.5 Vitakem Nutraceuticals Recent Developments
8 North America
  1. 8.1 North America Hospital and Nursing Home Probiotics Market Size by Type
  2. 8.1.1 North America Hospital and Nursing Home Probiotics Revenue by Type (2021-2032)
  3. 8.1.2 North America Hospital and Nursing Home Probiotics Sales by Type (2021-2032)
  4. 8.1.3 North America Hospital and Nursing Home Probiotics Price by Type (2021-2032)
  5. 8.2 North America Hospital and Nursing Home Probiotics Market Size by Application
  6. 8.2.1 North America Hospital and Nursing Home Probiotics Revenue by Application (2021-2032)
  7. 8.2.2 North America Hospital and Nursing Home Probiotics Sales by Application (2021-2032)
  8. 8.2.3 North America Hospital and Nursing Home Probiotics Price by Application (2021-2032)
  9. 8.3 North America Hospital and Nursing Home Probiotics Market Size by Country
  10. 8.3.1 North America Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hospital and Nursing Home Probiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hospital and Nursing Home Probiotics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Hospital and Nursing Home Probiotics Market Size by Type
  2. 9.1.1 Europe Hospital and Nursing Home Probiotics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hospital and Nursing Home Probiotics Sales by Type (2021-2032)
  4. 9.1.3 Europe Hospital and Nursing Home Probiotics Price by Type (2021-2032)
  5. 9.2 Europe Hospital and Nursing Home Probiotics Market Size by Application
  6. 9.2.1 Europe Hospital and Nursing Home Probiotics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hospital and Nursing Home Probiotics Sales by Application (2021-2032)
  8. 9.2.3 Europe Hospital and Nursing Home Probiotics Price by Application (2021-2032)
  9. 9.3 Europe Hospital and Nursing Home Probiotics Market Size by Country
  10. 9.3.1 Europe Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hospital and Nursing Home Probiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hospital and Nursing Home Probiotics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Hospital and Nursing Home Probiotics Market Size by Type
  2. 10.1.1 China Hospital and Nursing Home Probiotics Revenue by Type (2021-2032)
  3. 10.1.2 China Hospital and Nursing Home Probiotics Sales by Type (2021-2032)
  4. 10.1.3 China Hospital and Nursing Home Probiotics Price by Type (2021-2032)
  5. 10.2 China Hospital and Nursing Home Probiotics Market Size by Application
  6. 10.2.1 China Hospital and Nursing Home Probiotics Revenue by Application (2021-2032)
  7. 10.2.2 China Hospital and Nursing Home Probiotics Sales by Application (2021-2032)
  8. 10.2.3 China Hospital and Nursing Home Probiotics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hospital and Nursing Home Probiotics Market Size by Type
  2. 11.1.1 Asia Hospital and Nursing Home Probiotics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hospital and Nursing Home Probiotics Sales by Type (2021-2032)
  4. 11.1.3 Asia Hospital and Nursing Home Probiotics Price by Type (2021-2032)
  5. 11.2 Asia Hospital and Nursing Home Probiotics Market Size by Application
  6. 11.2.1 Asia Hospital and Nursing Home Probiotics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hospital and Nursing Home Probiotics Sales by Application (2021-2032)
  8. 11.2.3 Asia Hospital and Nursing Home Probiotics Price by Application (2021-2032)
  9. 11.3 Asia Hospital and Nursing Home Probiotics Market Size by Country
  10. 11.3.1 Asia Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hospital and Nursing Home Probiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hospital and Nursing Home Probiotics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hospital and Nursing Home Probiotics Market Size by Type
  2. 12.1.1 SAMEA Hospital and Nursing Home Probiotics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hospital and Nursing Home Probiotics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hospital and Nursing Home Probiotics Price by Type (2021-2032)
  5. 12.2 SAMEA Hospital and Nursing Home Probiotics Market Size by Application
  6. 12.2.1 SAMEA Hospital and Nursing Home Probiotics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hospital and Nursing Home Probiotics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hospital and Nursing Home Probiotics Price by Application (2021-2032)
  9. 12.3 SAMEA Hospital and Nursing Home Probiotics Market Size by Country
  10. 12.3.1 SAMEA Hospital and Nursing Home Probiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hospital and Nursing Home Probiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hospital and Nursing Home Probiotics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hospital and Nursing Home Probiotics Value Chain Analysis
  2. 13.1.1 Hospital and Nursing Home Probiotics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hospital and Nursing Home Probiotics Production Mode & Process
  6. 13.2 Hospital and Nursing Home Probiotics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hospital and Nursing Home Probiotics Distributors
  9. 13.2.3 Hospital and Nursing Home Probiotics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst